CN Patent

CN114324900A — 一种促卵泡激素的应用

Assigned to Shanghai Pulmonary Hospital · Expires 2022-04-12 · 4y expired

What this patent protects

本发明涉及一种检测促卵泡激素的制剂在制备预测男性特发性肺动脉高压患者生存率试剂盒中的应用。本发明初步揭示了促卵泡激素水平与男性特发性肺动脉高压患者疾病严重程度显著相关，特别是促卵泡激素水平较高的患者具有较低的生存率。

USPTO Abstract

本发明涉及一种检测促卵泡激素的制剂在制备预测男性特发性肺动脉高压患者生存率试剂盒中的应用。本发明初步揭示了促卵泡激素水平与男性特发性肺动脉高压患者疾病严重程度显著相关，特别是促卵泡激素水平较高的患者具有较低的生存率。

Drugs covered by this patent

Patent Metadata

Patent number
CN114324900A
Jurisdiction
CN
Classification
—
Expires
2022-04-12
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Pulmonary Hospital
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.